BMY
Bristol-Myers Squibb Company
61.20$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.4% | 22.7% | 25.4% | 28.0% | 28.7% | 34.0% | 49.0% | 42.3% | 42.6% | 43.7% | 43.2% | 28.9% | |
| 75.6% | 77.3% | 74.6% | 72.0% | 71.3% | 66.0% | 51.0% | 57.7% | 57.4% | 56.3% | 56.8% | 71.1% | |
| 25.5% | 24.4% | 22.7% | 23.9% | 22.7% | 22.8% | 22.5% | 20.6% | 20.4% | 20.5% | 20.3% | 20.6% | |
| 5.5% | 1.0% | 0.5% | 0.8% | 20.2% | 18.6% | 18.0% | 16.6% | 16.9% | 13.9% | 13.2% | 11.7% | |
| 55.8% | 53.6% | 48.0% | 46.8% | 42.9% | 41.4% | 40.5% | 37.1% | 37.3% | 37.5% | 36.8% | 42.6% | |
| 19.7% | 23.8% | 26.7% | 25.2% | 28.3% | 24.6% | 10.6% | 20.6% | 20.1% | 18.8% | 20.0% | 28.5% | |
| 1.3% | 1.1% | 0.9% | 0.9% | 0.8% | 2.5% | 3.3% | 2.9% | 2.7% | 2.6% | 4.0% | 3.9% | |
| 15.0% | 12.5% | 30.4% | 24.7% | 26.5% | 19.0% | -16.2% | 17.5% | 16.7% | 18.8% | -17.3% | 19.4% | |
| 2.2% | 2.7% | 7.2% | 20.0% | 4.5% | 5.8% | 5.0% | 2.3% | 3.0% | 0.9% | 1.1% | 4.7% | |
| 12.6% | 9.5% | 22.9% | 4.8% | 21.8% | 13.2% | -21.2% | 15.1% | 13.7% | 17.8% | -18.5% | 14.6% | |
| 19.2% | 15.9% | 33.3% | 29.4% | 30.1% | 28.2% | 11.6% | 43.4% | 41.6% | 43.0% | 6.6% | 31.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.